Vanguard Global Advisers’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52M Sell
101,499
-7,506
-7% -$365K ﹤0.01% 761
2026
Q1
$4.68M Buy
+109,005
New +$4.69M ﹤0.01% 790

Other funds holding EXEL

Vanguard Global Advisers's EXEL Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Exelixis (EXEL) stake by 6.9% in Q2 2026, selling an estimated $365K and leaving 101,499 shares worth $5.52M. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Vanguard Global Advisers first reported a position in EXEL in Q1 2026 and has held it in 2 quarters since. 741 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Vanguard Global Advisers held 101,499 shares of Exelixis worth $5.52M as of Q2 2026.
  • Vanguard Global Advisers sold 7,506 Exelixis shares in Q2 2026, an estimated $365K.
  • Exelixis made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #761 holding.
  • Vanguard Global Advisers first reported a position in Exelixis in Q1 2026 and has held it in 2 quarters since.
  • 741 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.